Industries > Pharma > Non-Invasive Prenatal Testing (NIPT) Market Report 2020-2030

Non-Invasive Prenatal Testing (NIPT) Market Report 2020-2030

Revenue Prospects by Product & Service (Consumables (Assay Kits & Reagents, Disposables), Instruments (Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Next-Generation Sequencing Systems), Services), Method (Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests, Ultrasound Detection), Application (Microdeletion Syndrome, Trisomy, Other Applications), Gestation Duration (0-12 Weeks, 13-24 Weeks, 25-36 Weeks), Pregnancy Risk (Low Risk Pregnancy Testing, High & Average Risk Pregnancy Testing), End Users (Diagnostic Laboratories, Hospitals) and Geography

PAGES: 182
PRODUCT CODE: PHA0611
SUBMARKET:

Clear
WOOCS 2.2.1
SKU: PHA0611 Category: Tag:

Non-Invasive Prenatal Testing (NIPT)– our new study reveals trends, R&D progress, and predicted revenues
Where is the Non-Invasive Prenatal Testing (NIPT) market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 168 tables, 50 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Non-Invasive Prenatal Testing (NIPT) Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 6 segmentations of the Non-Invasive Prenatal Testing (NIPT) market, with forecasts for 3 Product & Services, 3 Methods, 3 Applications, 3 Gestation Duration, 2 Pregnancy Risk, 2 End Users, each forecasted at a global and regional level.

Global Non-Invasive Prenatal Testing (NIPT) Market by Product & Service
– Consumables
– Instruments
– Services

Global Non-Invasive Prenatal Testing (NIPT) Market by Method
– Biochemical Screening Tests
– Cell-Free Dna in Maternal Plasma Tests
– Ultrasound Detection

Global Non-Invasive Prenatal Testing (NIPT) Market by Application
– Microdeletion Syndrome
– Trisomy
– Other Applications

Global Non-Invasive Prenatal Testing (NIPT) Market by Gestation Duration
– 0-12 Weeks
– 13-24 Weeks
– 25-36 Weeks

Global Non-Invasive Prenatal Testing (NIPT) Market by Pregnancy Risk
– Low Risk Pregnancy Testing
– High & Average Risk Pregnancy Testing
Global Non-Invasive Prenatal Testing (NIPT) Market by End Users
– Diagnostic Laboratories
– Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

– North America:
– U.S.
– Canada

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia
– ASEAN
– Rest of Asia-Pacific

– MEA:
– GCC Countries
– South Africa
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Non-Invasive Prenatal Testing (NIPT) market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Non-Invasive Prenatal Testing (NIPT) Market will surpass $4 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Non-Invasive Prenatal Testing (NIPT) Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 6 segmentations of the Non-Invasive Prenatal Testing (NIPT) market, with forecasts for 3 Product & Services, 3 Methods, 3 Applications, 3 Gestation Duration, 2 Pregnancy Risk, 2 End Users, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Non-Invasive Prenatal Testing (NIPT) market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for 16 major companies involved in the Non-Invasive Prenatal Testing (NIPT) market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Non-Invasive Prenatal Testing (NIPT) market and leading companies. You will find data, trends and predictions.

Get our report today The Non-Invasive Prenatal Testing (NIPT) Market Forecast 2020-2030: Revenue Prospects by Product & Service {Consumables (Assay Kits & Reagents, Disposables), Instruments (Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Next-Generation Sequencing Systems), Services}, Method (Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests, Ultrasound Detection), Application (Microdeletion Syndrome, Trisomy, Other Applications), Gestation Duration (0-12 Weeks, 13-24 Weeks, 25-36 Weeks), Pregnancy Risk (Low Risk Pregnancy Testing, High & Average Risk Pregnancy Testing), End Users (Diagnostic Laboratories, Hospitals), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Non-Invasive Prenatal Testing (NIPT) Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Non-Invasive Prenatal Testing (NIPT) Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Pharma Contract Manufacturing Market Report 2020-2030

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry.

10 August 2020

READ

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Categories

Category